{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:13:09Z","timestamp":1760145189523,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.repc.2018.06.012","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T12:13:29Z","timestamp":1560773609000},"page":"325-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ser\u00e1 a s\u00edndrome metab\u00f3lica um marcador de progn\u00f3stico em doentes com elevado risco cardiovascular? Um estudo de coorte a longo\u2010prazo"],"prefix":"10.1016","volume":"38","author":[{"given":"Ana Teresa","family":"Tim\u00f3teo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Mota Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Cruz Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2018.06.012_bib0155","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular diseases in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.repc.2018.06.012_bib0160","unstructured":"Programa Nacional para as doen\u00e7as c\u00e9rebro\u2010cardiovasculares 2017. Ed. Dire\u00e7\u00e3o Geral Sa\u00fade, Lisboa, Setembro 2017, p\u00e1gina 5."},{"key":"10.1016\/j.repc.2018.06.012_bib0165","unstructured":"Causas de Morte 2015. Ed. Instituto Nacional de Estat\u00edstica, I.P., Lisboa, Maio 2017, p\u00e1ginas 31 e 96."},{"key":"10.1016\/j.repc.2018.06.012_bib0170","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta\u2010analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am J Med."},{"key":"10.1016\/j.repc.2018.06.012_bib0175","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta\u2010analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.repc.2018.06.012_bib0180","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk: a systematic review and meta\u2010analysis","volume":"56","author":"Motillo","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.repc.2018.06.012_bib0185","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2012.05.018","article-title":"Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow\u2010up. A prospective study","volume":"223","author":"Novo","year":"2012","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.repc.2018.06.012_bib0190","first-page":"1495","article-title":"(em nome dos investigadores do estudo VALSIM) S\u00edndrome Metab\u00f3lica em Portugal: Preval\u00eancia e Implica\u00e7\u00f5es no Risco Cardiovascular \u2013 Resultados do Estudo VALSIM","volume":"27","author":"Fi\u00faza","year":"2008","journal-title":"Rev Port Cardiol."},{"key":"10.1016\/j.repc.2018.06.012_bib0195","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacl.2017.06.017","article-title":"Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM\u2010HIGH trial","volume":"11","author":"Lyubarova","year":"2017","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.repc.2018.06.012_bib0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1253\/circj.72.415","article-title":"Impact of metabolic syndrome on the long\u2010term survival of patients with acute myocardial infarction: potential association with C\u2010reactive protein","volume":"72","author":"Takano","year":"2008","journal-title":"Circ J."},{"key":"10.1016\/j.repc.2018.06.012_bib0205","first-page":"83","article-title":"Prevalence of metabolic syndrome and diabetes on a high\u2010risk population with suspected coronary artery disease","volume":"25","author":"- Tim\u00f3teo","year":"2012","journal-title":"Acta Med Port."},{"key":"10.1016\/j.repc.2018.06.012_bib0210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1751-7176.2012.00630.x","article-title":"Can metabolic syndrome presence predict carotid intima\u2010media thickness?","volume":"14","author":"Tim\u00f3teo","year":"2012","journal-title":"J Clin Hypert (Greenwich)"},{"key":"10.1016\/j.repc.2018.06.012_bib0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0003319711435935","article-title":"Carotid intima\u2010media thickness and carotid plaques improves prediction of obstructive angiographic coronary artery disease in women","volume":"64","author":"Tim\u00f3teo","year":"2013","journal-title":"Angiology."},{"key":"10.1016\/j.repc.2018.06.012_bib0220","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.repc.2012.03.006","article-title":"Cruz Ferreira. Does metabolic syndrome predict significant angiographic coronary artery disease?","volume":"31","author":"Tim\u00f3teo","year":"2012","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2018.06.012_bib0225","first-page":"2735","article-title":"Diagnosis and management of the metabolic syndrome","volume":"112","author":"Grundy","year":"2005","journal-title":"An American Heart Association \/National Heart, Lung, and Blood Institute scientific statement Circulation."},{"key":"10.1016\/j.repc.2018.06.012_bib0230","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.repc.2018.06.012_bib0235","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2006.12.028","article-title":"Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions","volume":"49","author":"Amano","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.repc.2018.06.012_bib0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0735-1097(99)00533-1","article-title":"Morphology of vulnerable coronary plaque: insights from follow\u2010up of patients examined by intravascular ultrasound before an acute coronary syndrome","volume":"35","author":"Yamagishi","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.repc.2018.06.012_bib0245","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.numecd.2010.09.009","article-title":"Metabolic syndrome and coronary heart disease among Spanish male workers: a case\u2010control study of MESYAS","volume":"22","author":"Laclaustra","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.repc.2018.06.012_bib0250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.atherosclerosis.2011.01.007","article-title":"Burden of subclinical cardiovascular disease in \u201cmetabolically benign\u201d and \u201cat risk\u201d overweight and obese women: The Study of Women's Health Across the Nation (SWAN)","volume":"217","author":"Khan","year":"2011","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.repc.2018.06.012_bib0255","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/oby.2010.168","article-title":"Cardiovascular disease risk of abdominal obesity versus metabolic abnormalities","volume":"19","author":"Wildman","year":"2011","journal-title":"Obesity."},{"key":"10.1016\/j.repc.2018.06.012_bib0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000076695","article-title":"Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?","volume":"101","author":"Anderson","year":"2004","journal-title":"Cardiology."},{"key":"10.1016\/j.repc.2018.06.012_bib0265","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1253\/circj.70.1531","article-title":"Prognostic value of the metabolic syndrome for long\u2010term outcomes in patients undergoing percutaneous coronary intervention","volume":"70","author":"Kasai","year":"2006","journal-title":"Circ J."},{"key":"10.1016\/j.repc.2018.06.012_bib0270","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1253\/circj.CJ-08-1122","article-title":"Impact of metabolic syndrome on 10\u2010year clinical outcomes among patients with acute coronary syndromes","volume":"73","author":"Dohi","year":"2009","journal-title":"Circ J."},{"key":"10.1016\/j.repc.2018.06.012_bib0275","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1253\/circj.CJ-15-0942","article-title":"Prognostic impact of metabolic syndrome in patients with chronic heart failure. A multicenter prospective cohort study","volume":"80","author":"Tadaki","year":"2016","journal-title":"Circ J."},{"key":"10.1016\/j.repc.2018.06.012_bib0280","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5603\/CJ.a2016.0017","article-title":"Metabolic syndrome is associated with different clinical outcome after cardiac resynchronization therapy in patients with ischemic and non\u2010ischemic cardiomyopathy","volume":"23","author":"Szepietowska","year":"2016","journal-title":"Cardiol J."},{"key":"10.1016\/j.repc.2018.06.012_bib0285","doi-asserted-by":"crossref","first-page":"794","DOI":"10.5603\/KP.2018.0077","article-title":"The influence of metabolic syndrome coexistence in the prognosis of patients with heart failure without atrial fibrillation Analysis of Polish data for the pilot survey for the ESC Heart Failure Registry","volume":"76","author":"Welnicki","year":"2018","journal-title":"Kardiol Polska."},{"key":"10.1016\/j.repc.2018.06.012_bib0290","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/eurheartj\/ehv350","article-title":"The role of metabolic syndrome in heart failure","volume":"36","author":"Perrone-Filadi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2018.06.012_bib0295","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/HJH.0b013e328337a9e3","article-title":"Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events","volume":"28","author":"Mancia","year":"2010","journal-title":"J Hypertens."},{"key":"10.1016\/j.repc.2018.06.012_bib0300","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"N Engl J Med."}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255118300696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255118300696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:07:27Z","timestamp":1760108847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255118300696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0870255118300696"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2018.06.012","relation":{},"ISSN":["0870-2551"],"issn-type":[{"type":"print","value":"0870-2551"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ser\u00e1 a s\u00edndrome metab\u00f3lica um marcador de progn\u00f3stico em doentes com elevado risco cardiovascular? Um estudo de coorte a longo\u2010prazo","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2018.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}